基因表現市場－全球產業規模、佔有率、趨勢、機會及預測，依製程、產品、產能、應用、技術、地區及競爭格局分類，2020-2030年預測

2024年全球基因表現市場規模為157.8億美元，預計2030年將以5.58%的複合年成長率成長至218.6億美元。基因表現是指將DNA中的遺傳訊息轉化為功能性基因產物（主要是蛋白質或RNA分子）的基本細胞過程，決定特定的細胞屬性和功能。基因組研究和定序技術的不斷進步、全球慢性病和傳染病發病率的上升（需要精準的診斷和預後工具）以及生物製藥研發領域為發現新型療法而不斷成長的投資，都顯著推動了該市場的成長。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球基因表現市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依流程（樣本採集、純化、cDNA合成與轉化、PCR分析、數據分析與解釋）
  • 依產品分類（試劑盒及試劑、DNA晶片、其他）
  • 依容量分類（低至中 Plex，高 Plex）
  • 按應用領域（藥物發現與開發、臨床診斷、生物技術與微生物學、其他）
  • 依技術（RNA表現、啟動子分析、蛋白質表現及翻譯後修飾分析）
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美基因表現市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲基因表現市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區基因表現市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲基因表現市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美基因表現市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球基因表現市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Catalent, Inc.
• Quest Diagnostics Incorporated
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Luminex Corporation
• Takara Bio USA, Inc.
• Danaher Corporation

第16章：策略建議

第17章調查會社について,免責事項

The Global Gene Expression Market, valued at USD 15.78 Billion in 2024, is projected to experience a CAGR of 5.58% to reach USD 21.86 Billion by 2030. Gene expression delineates the fundamental cellular process whereby genetic information from DNA is converted into functional gene products, primarily proteins or RNA molecules, thereby dictating specific cellular attributes and functions. The market's expansion is significantly propelled by continuous advancements in genomic research and sequencing technologies, the escalating global incidence of chronic and infectious diseases necessitating precise diagnostic and prognostic tools, and growing investments in biopharmaceutical research and development for novel therapeutic discovery.

Key Market Drivers

The global gene expression market is significantly influenced by continued advancements in genomics and biotechnology, which serve as foundational catalysts for innovation. These developments encompass sophisticated sequencing technologies, refined gene editing tools such as CRISPR, and comprehensive omics approaches, all of which enhance the depth and efficiency of gene expression analysis. This continuous evolution in scientific capabilities enables researchers to explore complex biological systems with unprecedented resolution, driving the discovery of new therapeutic targets and diagnostic biomarkers.

Key Market Challenges

A significant challenge impeding the growth of the Global Gene Expression Market is the substantial capital outlay required for advanced analysis platforms. Implementing high-throughput sequencing technologies and establishing complex bioinformatics infrastructure necessitates considerable upfront investment. This financial burden restricts broader adoption, particularly among smaller research entities, emerging biotechnology firms, and academic laboratories operating with limited budgets. Such high initial and ongoing maintenance costs can delay or prevent these organizations from acquiring essential equipment and developing the necessary expertise, thereby hindering the widespread application of gene expression technologies across various research and clinical domains.

Key Market Trends

The expansion of spatial transcriptomics significantly advances gene expression analysis by offering critical contextual information, enabling visualization of gene activity within its native tissue microenvironment. This capability is essential for unraveling intricate disease mechanisms, identifying precise therapeutic targets, and discovering biomarkers. Spatial transcriptomics provides insights into cellular heterogeneity and cell-to-cell interactions, fostering notable market growth. For instance, in June 2024, Moleculent AB secured USD 25.0 million in Series A financing to advance its spatial mapping of cell-cell communication. This development is supported by broader industry investment, with the European Federation of Pharmaceutical Industries and Associations reporting an estimated €50,000 million invested in research and development in Europe in 2023.

Key Market Players

• Catalent, Inc.
• Quest Diagnostics Incorporated
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• PerkinElmer, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Luminex Corporation
• Takara Bio USA, Inc.
• Danaher Corporation

Report Scope:

In this report, the Global Gene Expression Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Market, By Process:

• Sample Collection
• Purification
• cDNA synthesis & conversion
• PCR Analysis
• Data analysis & interpretation

Gene Expression Market, By Product:

• Kits & Reagents
• DNA Chips
• Others

Gene Expression Market, By Capacity:

• Low- to Mid- Plex
• High-Plex

Gene Expression Market, By Application:

• Drug Discovery & Development
• Clinical Diagnostics
• Biotech & Microbiology
• Others

Gene Expression Market, By Technique:

• RNA Expression
• Promoter Analysis
• Protein Expression& Posttranslational Modification Analysis

Gene Expression Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Gene Expression Market.

Available Customizations:

Global Gene Expression Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Expression Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation)
  • 5.2.2. By Product (Kits & Reagents, DNA Chips, Others)
  • 5.2.3. By Capacity (Low- to Mid- Plex, High-Plex)
  • 5.2.4. By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others)
  • 5.2.5. By Technique (RNA Expression, Promoter Analysis, Protein Expression& Posttranslational Modification Analysis)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Gene Expression Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Process
  • 6.2.2. By Product
  • 6.2.3. By Capacity
  • 6.2.4. By Application
  • 6.2.5. By Technique
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gene Expression Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Process
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Capacity
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By Technique
  • 6.3.2. Canada Gene Expression Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Process
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Capacity
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By Technique
  • 6.3.3. Mexico Gene Expression Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Process
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Capacity
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By Technique

7. Europe Gene Expression Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Process
  • 7.2.2. By Product
  • 7.2.3. By Capacity
  • 7.2.4. By Application
  • 7.2.5. By Technique
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gene Expression Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Process
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Capacity
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By Technique
  • 7.3.2. France Gene Expression Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Process
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Capacity
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By Technique
  • 7.3.3. United Kingdom Gene Expression Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Process
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Capacity
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By Technique
  • 7.3.4. Italy Gene Expression Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Process
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Capacity
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By Technique
  • 7.3.5. Spain Gene Expression Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Process
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Capacity
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By Technique

8. Asia Pacific Gene Expression Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Process
  • 8.2.2. By Product
  • 8.2.3. By Capacity
  • 8.2.4. By Application
  • 8.2.5. By Technique
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Gene Expression Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Process
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Capacity
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By Technique
  • 8.3.2. India Gene Expression Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Process
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Capacity
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By Technique
  • 8.3.3. Japan Gene Expression Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Process
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Capacity
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By Technique
  • 8.3.4. South Korea Gene Expression Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Process
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Capacity
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By Technique
  • 8.3.5. Australia Gene Expression Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Process
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Capacity
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By Technique

9. Middle East & Africa Gene Expression Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Process
  • 9.2.2. By Product
  • 9.2.3. By Capacity
  • 9.2.4. By Application
  • 9.2.5. By Technique
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Gene Expression Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Process
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Capacity
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By Technique
  • 9.3.2. UAE Gene Expression Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Process
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Capacity
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By Technique
  • 9.3.3. South Africa Gene Expression Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Process
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Capacity
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By Technique

10. South America Gene Expression Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Process
  • 10.2.2. By Product
  • 10.2.3. By Capacity
  • 10.2.4. By Application
  • 10.2.5. By Technique
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Gene Expression Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Process
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Capacity
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By Technique
  • 10.3.2. Colombia Gene Expression Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Process
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Capacity
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By Technique
  • 10.3.3. Argentina Gene Expression Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Process
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Capacity
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By Technique

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Gene Expression Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Catalent, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Quest Diagnostics Incorporated
• 15.3. F. Hoffmann-La Roche Ltd
• 15.4. Illumina, Inc.
• 15.5. PerkinElmer, Inc.
• 15.6. Thermo Fisher Scientific, Inc.
• 15.7. Promega Corporation
• 15.8. Luminex Corporation
• 15.9. Takara Bio USA, Inc.
• 15.10. Danaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer